Arg120
Javascript is not enabled on this browser. This site will not work properly without Javascript.
PhosphoSitePlus Homepage PhosphoSitePlus®
Powered by Cell Signaling Technology
Home > Mono-methylation Site Page: > Arg120  -  CCDC9 (mouse)

Site Information
DGAGEQLrGGPGGrG   SwissProt Entrez-Gene
Blast this site against: NCBI  SwissProt  PDB 
Site Group ID: 6010218

In vivo Characterization
Methods used to characterize site in vivo:
mass spectrometry ( 1 , 2 , 3 , 4 , 5 , 6 , 7 , 8 , 9 , 10 , 11 , 12 , 13 , 14 , 15 , 16 , 17 , 18 , 19 , 20 , 21 )
Disease tissue studied:
testicular cancer ( 12 )
Relevant cell line - cell type - tissue:
brain ( 1 , 2 ) , embryo ( 1 , 3 , 4 , 5 , 6 , 7 , 8 , 9 , 10 ) , kidney ( 13 , 15 ) , lung ( 14 , 16 ) , MEF (fibroblast) ( 17 , 18 , 19 , 20 ) , P19 (testicular) ( 12 ) , PYS-2 (epithelial) ( 11 )

References 

1

Guo A, et al. (2014) Immunoaffinity enrichment and mass spectrometry analysis of protein methylation. Mol Cell Proteomics 13, 372-87
24129315   Curated Info

2

Guo A (2013) CST Curation Set: 18333; Year: ; Biosample/Treatment: tissue, brain/-; Disease: -; SILAC: -;
Curated Info

3

Guo A (2013) CST Curation Set: 18340; Year: ; Biosample/Treatment: tissue, embryo/-; Disease: -; SILAC: -;
Curated Info

4

Guo A (2013) CST Curation Set: 18342; Year: ; Biosample/Treatment: tissue, embryo/-; Disease: -; SILAC: -;
Curated Info

5

Guo A (2013) CST Curation Set: 18344; Year: ; Biosample/Treatment: tissue, embryo/-; Disease: -; SILAC: -;
Curated Info

6

Guo A (2013) CST Curation Set: 18345; Year: ; Biosample/Treatment: tissue, embryo/-; Disease: -; SILAC: -;
Curated Info

7

Guo A (2013) CST Curation Set: 18346; Year: ; Biosample/Treatment: tissue, embryo/-; Disease: -; SILAC: -;
Curated Info

8

Guo A (2013) CST Curation Set: 18347; Year: ; Biosample/Treatment: tissue, embryo/-; Disease: -; SILAC: -;
Curated Info

9

Guo A (2013) CST Curation Set: 18348; Year: ; Biosample/Treatment: tissue, embryo/-; Disease: -; SILAC: -;
Curated Info

10

Guo A (2013) CST Curation Set: 18349; Year: ; Biosample/Treatment: tissue, embryo/-; Disease: -; SILAC: -;
Curated Info

11

Zhou J (2010) CST Curation Set: 9115; Year: 2010; Biosample/Treatment: cell line, PY2/untreated; Disease: -; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: m1R
Curated Info

12

Zhou J (2010) CST Curation Set: 9114; Year: 2010; Biosample/Treatment: cell line, P19/untreated; Disease: testicular cancer; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: m1R
Curated Info

13

Zhou J (2009) CST Curation Set: 7948; Year: 2009; Biosample/Treatment: tissue, kidney/untreated; Disease: -; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: m1R
Curated Info

14

Zhou J (2009) CST Curation Set: 7946; Year: 2009; Biosample/Treatment: tissue, lung/untreated; Disease: -; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: m1R
Curated Info

15

Zhou J (2009) CST Curation Set: 7947; Year: 2009; Biosample/Treatment: tissue, kidney/untreated; Disease: -; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: m1R
Curated Info

16

Zhou J (2009) CST Curation Set: 7945; Year: 2009; Biosample/Treatment: tissue, lung/untreated; Disease: -; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: m1R
Curated Info

17

Zhou J (2009) CST Curation Set: 6011; Year: 2012; Biosample/Treatment: cell line, MEF/untreated; Disease: -; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: m1R
Curated Info

18

Zhou J (2009) CST Curation Set: 6009; Year: 2012; Biosample/Treatment: cell line, MEF/untreated; Disease: -; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: m1R
Curated Info

19

Zhou J (2009) CST Curation Set: 6008; Year: 2012; Biosample/Treatment: cell line, MEF/untreated; Disease: -; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: m1R
Curated Info

20

Zhou J (2009) CST Curation Set: 6014; Year: 2012; Biosample/Treatment: cell line, MEF/untreated; Disease: -; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: m1R
Curated Info

21

Rikova K (2008) CST Curation Set: 4937; Year: 2008; Biosample/Treatment: cell line, Dana Farber-L1/untreated; Disease: -; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: m1R
Curated Info